Please assess the completion status of the following clinical trial:

Trial Title: Spinal Analgesia Versus No Analgesia: Study for External Cephalic Version

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA I-II~* 37 + weeks gestation~* No previous attempt at ECV in this pregnancy~* No fetal abnormality~Exclusion Criteria:~* No previous uterine surgery~* Any contraindication for vaginal delivery~* Contra-indications to regional analgesia: uncorrected hypovolemia, coagulopathy (including anti-coagulants but not low-dose \[100mg\] aspirin), infection or inflammation of the skin overlying the lumbar area, raised intra-cranial pressure, hypersensitivity to amide local anesthetic agents.~* Patient refusal for regional analgesia~* Previous history of meningitis, neuropathy, or severe back pain with neurological radiation~* Poor communication (no Hebrew or English spoken, deafness, blindness, serious intellectual impairment or psychiatric disorder)~* Morbid obesity

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- External cephalic version with spinal anesthesia (Type: EXPERIMENTAL): External cephalic version with spinal anesthesia
- External cephalic version without spinal anesthesia (Type: ACTIVE_COMPARATOR): External cephalic version without spinal anesthesia

Based on this trial design, predict the completion outcome and termination type (if applicable).